RSCM
SPRB

Rock Springs Capital Management’s Spruce Biosciences SPRB Stock Holding History

Rock Springs Capital Management’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,788
Closed -$757K – 104
2025
Q1 		$757K Hold
34,788
– – 0.04% 92
2024
Q4 		$1.1M Hold
34,788
– – 0.04% 99
2024
Q3 		$1.24M Hold
34,788
– – 0.04% 101
2024
Q2 		$1.35M Hold
34,788
– – 0.04% 104
2024
Q1 		$2.05M Hold
34,788
– – 0.05% 107
2023
Q4 		$7.64M Sell
34,788
-1,587
-4% -$183K 0.19% 76
2023
Q3 		$6.17M Hold
36,375
– – 0.17% 82
2023
Q2 		$5.87M Hold
36,375
– – 0.14% 86
2023
Q1 		$6.03M Buy
36,375
+14,739
+68% +$2.74M 0.14% 85
2022
Q4 		$1.78M Hold
21,636
– – 0.04% 105
2022
Q3 		$2.22M Hold
21,636
– – 0.06% 111
2022
Q2 		$2.82M Hold
21,636
– – 0.08% 107
2022
Q1 		$3.26M Hold
21,636
– – 0.08% 117
2021
Q4 		$7.24M Buy
21,636
+68
+0.3% +$20.2K 0.17% 105
2021
Q3 		$9.72M Buy
21,568
+168
+0.8% +$105K 0.2% 107
2021
Q2 		$18M Buy
21,400
+343
+2% +$366K 0.36% 82
2021
Q1 		$26.2M Sell
21,057
-690
-3% -$1.06M 0.57% 60
2020
Q4 		$39.6M Buy
+21,747
New +$36M 0.84% 42

Other funds holding SPRB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return

Rock Springs Capital Management's SPRB Position: Q2 2025 in Review

Rock Springs Capital Management sold out of Spruce Biosciences (SPRB) in Q2 2025, closing a stake of 34,788 shares — an estimated $757K sold.

Rock Springs Capital Management first reported a position in SPRB in Q4 2020 and held it in 18 quarters. The position peaked at $39.6M in Q4 2020. 3 funds tracked by Wall St. Rank hold SPRB as of Q2 2025.

  • Rock Springs Capital Management reported no remaining Spruce Biosciences position as of Q2 2025 after selling out during the quarter.
  • Rock Springs Capital Management sold 34,788 Spruce Biosciences shares in Q2 2025, an estimated $757K.
  • Rock Springs Capital Management first reported a position in Spruce Biosciences in Q4 2020 and held it in 18 quarters.
  • Rock Springs Capital Management's Spruce Biosciences position peaked at $39.6M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2025.

Based on Rock Springs Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.